Abiomed, Inc.ABMDNASDAQ
Loading
Free Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank29
3Y CAGR-37.4%
5Y CAGR+17.4%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
-37.4%/yr
vs -11.2%/yr prior
5Y CAGR
+17.4%/yr
Recent deceleration
Acceleration
-26.2pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
2.2x
Strong expansion
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2022 | 12.85% |
| 2021 | -18.35% |
| 2020 | 30.13% |
| 2019 | 52.32% |
| 2018 | 111.25% |
| 2017 | 5.77% |
| 2016 | 60.55% |
| 2015 | 84.02% |
| 2014 | -12.13% |
| 2013 | 1147.38% |